1. Home
  2. CANF vs DAKT Comparison

CANF vs DAKT Comparison

Compare CANF & DAKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.09

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$19.78

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
DAKT
Founded
1994
1968
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
1.0B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
CANF
DAKT
Price
$3.09
$19.78
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9,750.00
N/A
AVG Volume (30 Days)
614.9K
590.4K
Earning Date
03-26-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.75
Revenue
N/A
$608,932,000.00
Revenue This Year
$2,715,455.50
$12.94
Revenue Next Year
$101.06
$8.32
P/E Ratio
N/A
$26.07
Revenue Growth
N/A
6.89
52 Week Low
$0.17
$10.95
52 Week High
$10.40
$28.27

Technical Indicators

Market Signals
Indicator
CANF
DAKT
Relative Strength Index (RSI) 37.08 38.34
Support Level $0.59 $19.76
Resistance Level $4.74 $20.88
Average True Range (ATR) 0.19 0.80
MACD -0.05 -0.04
Stochastic Oscillator 15.66 28.32

Price Performance

Historical Comparison
CANF
DAKT

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

Share on Social Networks: